FDA DEVICE FACTS
R3 Anteverted Liners
Smith & Nephew, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Hip components are indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.
Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; treatments of nonunion, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, or Girdlestone resection; fracture-dislocation of the hip; and correction of deformity.
The R3 Acetabular System is for single use only and is intended for cementless use.
The above indication for use for the subject device, is identical to the R3 XLPE Liner cleared under K113848 and K093363, the REFLETION Acetabular System (K920430) and R3 XLPE Anteverted Liners (K102370).
Comparison of Technological Characteristics with the Predicate Device Intended Use: The proposed R3 Anterverted Liners have identical Intended use as the predicate R3 XLPE Liners Indication for Use: The proposed R3 Anterverted Liners have identical Indication for Use as the predicate R3 XLPE Liners Materials: The proposed R3 Anterverted Liners are manufactured by same material and manufacturing process as the predicate R3 XLPE Liners Design Features: The proposed R3 Anterverted Liners have overall same design features as the predicate R3 XLPE Liners. Sterilization: The proposed R3 Anterverted Liners and predicate R3 XLPE Liners are provided sterile by Ethylene Oxide for single-use.
Therefore, the technological characteristics of the subject device are the similar to the technological characteristics of the predicate device R3 XLPE Liners cleared under K113848 and K093363.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。